Somatic SF3B1 mutation was first reported in 34 MDS patients with defined syndromes such as ringed sideroblasts; refractory anemia with ringed sideroblasts; and refractory cytopenia with multilineage dysplasia and ringed sideroblasts [27]. Here, SF3B1 is linked to myelodysplastic syndrome.